News

Filter

Current filters:

None

8226 to 8235 of 96965 results

Seikagaku licenses lumbar disc herniation product to Kaken

13-05-2012

Japanese companies Seikagaku Corp (TYO: 4548) and Kaken Pharmaceutical (TYO: 4521) have concluded a basic…

Asia-PacificcondoliaseKaken PharmaLicensingPharmaceuticalSeikagaku

Big pharma and biotech increasingly tackling rare and niche diseases, new report finds

13-05-2012

Rare and niche diseases are being increasingly spotlighted by pharmaceutical and biotechnology corporations…

BiotechnologyPharmaceuticalRare diseasesResearch

Oncologists backing of combo products supporting cytotoxic market

13-05-2012

The popularity of combination therapies in the treatment of cancer is set to increase, which will help…

BiotechnologyGemzarMarkets & MarketingOncologyPharmaceuticalTaxotere

EU draft opinion on ACTA still flawed, says MSF, urging member states not to sign

11-05-2012

The European Union Parliament Committee on Development released its draft opinion this week on the Anti-Counterfeiting…

EuropeGenericsGlobalPatentsPharmaceuticalPolitics

UK's NICE negative on Sanofi's Jevtana, but backs Botox for migraine

11-05-2012

Confirming previous negative guidance (The Pharma Letter January 12), UK drugs watchdog the National…

AllerganBotoxEuropeJevtanaNeurologicalOncologyPharmaceuticalPricingRegulationSanofi

Ranbaxy sales rocket 55%, net rises four-fold

11-05-2012

Ranbaxy Laboratories (AB: BO), India's largest drugmaker, came in with a stompingly good set of financial…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

US FDA warns on safety of Celgene's Revlimid; new Ph III trial results

11-05-2012

The US Food and Drug Administration this week issued a notification of an increased risk of second primary…

BiotechnologyCelgeneOncologyRegulationResearchRevlimid

8226 to 8235 of 96965 results

Parexel

Parexel

Back to top